Patients younger than 18 with diagnosed COVID-19 have an increased risk for newly diagnosed diabetes greater than 30 days after acute infection, according to research published in the CDC’s Morbidity and Mortality Weekly Report. Catherine E. Barrett, PhD, and colleagues examined the risk for any new diabetes diagnosis greater than 30 days after acute infection with COVID-19 among patients younger than 18 using healthcare claims data from March 1, 2020 through February 26, 2021. The incidence was compared to that of individuals who did not receive a COVID-19 diagnosis during the pandemic or to those who received a pre-pandemic, nonCOVID-19 acute respiratory infection diagnosis. Analyses were replicated using a second data source from March 1, 2020 through June 28, 2021. In both databases, diabetes incidence was significantly higher among those with COVID-19 than those without COVID-19.
